Cargando…
Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection
Mutations at specific hotspots in non-coding regions of ADGRG6, PLEKHS1, WDR74, TBC1D12 and LEPROTL1 frequently occur in bladder cancer (BC). These mutations could function as biomarkers for the non-invasive detection of BC but this remains largely unexplored. Massively-parallel sequencing of non-co...
Autores principales: | Baxter, L., Gordon, N. S., Ott, S., Wang, J., Patel, P., Goel, A., Piechocki, K., Silcock, L., Sale, C., Zeegers, M. P., Cheng, K. K., James, N. D., Bryan, R. T., Ward, D. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852567/ https://www.ncbi.nlm.nih.gov/pubmed/36658180 http://dx.doi.org/10.1038/s41598-023-27675-4 |
Ejemplares similares
-
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014) -
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification
por: Ward, Douglas G., et al.
Publicado: (2019) -
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015) -
Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification
por: Snell, Kym I.E., et al.
Publicado: (2018) -
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)